The purpose of this pilot study is to test an exercise-based multidimensional intervention for patients with acute leukaemia undergoing consolidation chemotherapy in the context of outpatient management. Further, to test for safety, feasibility and preliminary effect on physical and functional capacity, and health related quality of life.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
20
The intervention is initiated during chemotherapy treatment (consolidation) in the outpatient clinic and continues for 6 weeks. The intervention is a three hour/wk supervised in-hospital programme of aerobic (stationary cycle) and functional muscle training, progressive relaxation training, nutrition supplement (protein and carbohydrate) immediately after training and two health-promoting counseling sessions - Further, patients are fitted with a step counter pedometer.
Copenhagen University Hospital
Copenhagen, Denmark
Herlev Hospital
Herlev, Denmark
Feasibility - adherence rates
Percentage of intervention participation
Time frame: Adherence to the intervention components from baseline to 6 weeks
Adverse events
Number and type of adverse events
Time frame: baseline to 6 weeks
6MWD
Change in distance in meter
Time frame: Change from baseline in 6MWD at 6 weeks
Attrition
Number of patients that withdrew from the project
Time frame: Withdrawal from the project from baseline to 6 weeks
Timed chair stand
Change in the number of repetitions
Time frame: Change from baseline in timed chair stand at 6 weeks
Timed bicep curl
Change in number of repetitions
Time frame: Change from baseline in timed bicep curl at 6 weeks
FACT-Anemia
Change in scores for quality of life/function
Time frame: Change from baseline in FACT-An at 6 weeks
HADS
Change in scores for emotional wellbeing
Time frame: Change from baseline in HADS at 6 weeks
SF36
Change in scores for general health
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Change from baseline in SF36 at 6 weeks
MDSAI
Change in scores for symptom burden
Time frame: Change from baseline over time (1,2,3,4,5,6 weeks)